Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 29:15:1021.
doi: 10.1186/s12885-015-2042-y.

Meningeal carcinomatosis underdiagnosis and overestimation: incidence in a large consecutive and unselected population of breast cancer patients

Gloria Mittica  1 , Rebecca Senetta  2 , Lorenzo Richiardi  3 , Roberta Rudà  4 , Renato Coda  5 , Isabella Castellano  6 , Anna Sapino  7 , Paola Cassoni  8
Affiliations

Meningeal carcinomatosis underdiagnosis and overestimation: incidence in a large consecutive and unselected population of breast cancer patients

Gloria Mittica et al. BMC Cancer. .

Abstract

Background: The incidence of meningeal carcinomatosis appears to be higher than in the past due to advances in neuro-imaging diagnostic techniques and improvements in cancer survival. Among solid tumors, breast cancer is the cancer most commonly associated with meningeal carcinomatosis, with an incidence rate of between 0.8 and 16%. Aim of this study has been i) to evaluate the incidence of meningeal carcinomatosis in a continuous breast cancer unselected series treated in a dedicated Breast Unit and ii) to define the clinico-pathological and molecular parameters associated with meningeal carcinomatosis development.

Methods: A retrospective series of 1915 consecutive patients surgically treated for breast cancer between 1998 and 2010 was collected. Clinico-pathological data were recorded from medical charts and pathological reports, including the date of development of symptomatic meningeal carcinomatosis. Meningeal carcinomatosis incidence was determined at both 5- and 10-year follow-ups.

Results: Three patients in the first 5 years of follow-up and six patients in 10 years of follow-up developed meningeal carcinomatosis. An incidence rate of 5.44 per 10,000 patients (95% CI: 1.75-16.9) was observed, with a 5-year risk of 0.3%. At 10-year follow up, the rate increased to 7.55 per 10,000 patients (95% CI: 3.39-16.8). In a univariate analysis, young age, tumor size larger than 15 mm, histological grade 3, more than three metastatic lymph nodes, negative estrogen receptor, positive HER2 and high proliferative index were significantly associated with meningeal carcinomatosis development.

Conclusions: In an unselected breast cancer population, meningeal carcinomatosis is a rare event that is associated with adverse prognostic factors. Meningeal carcinomatosis incidence is overestimated when recorded in biased/high-risk selected breast cancer patients and should not be considered to accurately reflect the overall breast cancer population.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Patient series included in the study
See this image and copyright information in PMC

References

    1. Van Horn A, Chamberlain MC. Neoplastic meningitis. J Support Oncol. 2012;10:45–53. doi: 10.1016/j.suponc.2011.06.002. - DOI - PubMed
    1. Meriggi F, Zaniboni A. Newer avenues for the treatment of leptomeningeal carcinomatosis. Cent Nerv Syst Agents Med Chem. 2011;11:38–44. doi: 10.2174/187152411794961068. - DOI - PubMed
    1. Kesari S, Batchelor TT. Leptomeningeal metastases. Neurol Clin N Am. 2003;21:25–66. doi: 10.1016/S0733-8619(02)00032-4. - DOI - PubMed
    1. Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM. Leptomeningeal metastases in the MRI era. Neurology. 2010;74:1449–54. doi: 10.1212/WNL.0b013e3181dc1a69. - DOI - PMC - PubMed
    1. Le Rhun E, Taillibert S, Chamberlain MC. Carcinomatous meningitis: leptomeningeal metastases in solid tumors. Surg Neurol Int. 2013;4(Suppl 4):265–88. - PMC - PubMed

Publication types